Patent details

EP3609891 Title: SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3609891
WO Application Number:
US2019036593
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP19745960.5
WO Publication Number:
WO2019241278
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
11/06/2019
Grant date:
11/02/2026
EP Publication Date:
19/02/2020
WO Publication Date:
19/12/2019
Claims Translations Received Date:
Claims Translation B1 Received Date:
06/03/2026
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
11/02/2026
EP B1 Publication Date:
11/02/2026
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
10/06/2039
Lapsed By Expiration Date:
Patent Validated Date:
18/03/2026
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
11/02/2026
 
 

 

Name:
Intra-Cellular Therapies, Inc.
Address:
135 Route 202/206, Suite 6, Bedminster, NJ 07921, United States of America (US)

Agent

Name:
dr. R.C. van Duijvenbode c.s.
From:
17/03/2026
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
LI, Peng
Address:
New York, New York 10016, United States of America (US)

2

Name:
ZHANG, Qiang
Address:
New York, New York 10016, United States of America (US)

Priority

1

Priority Patent Number:
201862780742 P
Priority Date:
17/12/2018
Priority Country:
United States of America (US)

2

Priority Patent Number:
201862683411 P
Priority Date:
11/06/2018
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
C07D 471/04; C07D 471/16; C07D 519/00;

Publication

Bulletin

1

Bulletin Heading:
EP3
Journal edition number:
11/26
Publication date:
18/03/2026
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

2

Bulletin Heading:
EP2
Journal edition number:
06/26
Publication date:
11/02/2026
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202612
Publication date:
18/03/2026
Description:
Application number/publication number of the divisional application (Art. 76) changed

2

Issue number:
202607
Publication date:
11/02/2026
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
30/06/2026
Annual Fee Number:
8
Annual Fee Amount:
280 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
17/03/2026 Outgoing Correspondence Letter no formal defects 1 PDF /0/9/0/0/1/0801210090/docs/ep19745960.5_1_ep3609891700521l271.pdf
06/03/2026 Claims First filed claims 6 PDF /0/9/0/0/1/0801210090/docs/ep19745960.5_0_claims20260306104512733.pdf